SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/16/20 Angiodynamics Inc 8-K:7,9 1/16/20 2:4.3M Cadwalader Wickersh… LLP |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 20K 2: EX-99.1 Presentation Slides for the J.P. Morgan 38th HTML 32K Annual Healthcare Conference on January 16, 2020.
□ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
ANGO
|
NASDAQ Global Select Market
|
Exhibit No.
|
Description
|
Presentation slides for the J.P. Morgan 38th Annual Healthcare Conference on January 16, 2020.
|
ANGIODYNAMICS, INC.
(Registrant)
|
|||
Date: January 16, 2020
|
By:
|
/s/ Stephen A. Trowbridge | |
Stephen A. Trowbridge | |||
Senior Vice President, General Counsel and
|
|||
Interim Chief Financial Officer |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 1/16/20 | |||
5/31/19 | 10-K, 4, 8-K, DEF 14A | |||
List all Filings |